| RS143326262 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS143326637 |
OTOA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, Melanoma |
| RS143326964 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS143327210 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1433280953 |
ERI1
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Guo-Campeau type |
| RS143328343 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked sideroblastic anemia 1, Inborn genetic diseases |
| RS143329068 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperparathyroidism, Multiple endocrine neoplasia |
| RS143329328 |
TECRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1433293836 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS1433294475 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS143330463 |
IL2RB
|
Health Risk |
Conflicting classifications of pathogenicity |
IL2RB-related disorder, IL2RB-related disorder |
| RS1433306229 |
CREB3L3
|
Health Risk |
Pathogenic |
— |
| RS1433307898 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS143331003 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS143331971 |
MMP13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433323183 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS143333036 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Congenital factor V deficiency |
| RS143333246 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related disorder |
| RS143335921 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1433367660 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS143336823 |
TNS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143337663 |
FLRT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peripheral neuropathy, FLRT1-related disorder |
| RS143337739 |
NDUFS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 2 |
| RS143337771 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Acute febrile neutrophilic dermatosis |
| RS143338050 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS1433384279 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS143339036 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Cardiac arrhythmia |
| RS1433396777 |
HSPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2F, Inborn genetic diseases |
| RS143340522 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS143340609 |
FXN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143341041 |
CDK5RAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 3, primary |
| RS143341174 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Clear cell carcinoma of kidney |
| RS143341423 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS143341678 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS143341876 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniosynostosis syndrome, Trigonocephaly 1 |
| RS1433422316 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS1433422530 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1433428588 |
PLOD1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS143343083 |
GJB2
|
Health Risk |
Pathogenic |
Hearing impairment, Autosomal recessive nonsyndromic hearing loss 1A |
| RS1433432612 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS143343508 |
WDR35
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS143343647 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Muscular dystrophy |
| RS143344549 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS143344944 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS143344989 |
CABP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod synaptic disorder, congenital nonprogressive |
| RS143345726 |
MYOZ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS1433458409 |
ATP2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS1433459701 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS143346257 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
SKIC3-related disorder, SKIC3-related disorder |
| RS143346402 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrichotic osteochondrodysplasia Cantu type, Cardiovascular phenotype |
| RS1433471292 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS143347563 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS143348838 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, IVD-related disorder |
| RS1433489753 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS1433492944 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS143349452 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1433496791 |
PABPN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy 1 |
| RS1433497291 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS143350315 |
PRPF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, PRPF3-related disorder |
| RS1433509643 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS143351192 |
ZFHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
ZFHX3-related disorder, Melanoma |
| RS143351214 |
ERMARD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433513056 |
NUP133
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 8, Galloway-Mowat syndrome 8 |
| RS1433518605 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Leber congenital amaurosis 8 |
| RS143352280 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143352618 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS143353451 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1433540169 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS143354105 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1433543827 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS143354476 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433546528 |
IMPG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS143355224 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS143355299 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS143356203 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS143356409 |
DISP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433564897 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS143356896 |
ERCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS143357437 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1433582057 |
ACADS
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS143358506 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, ALPL-related disorder |
| RS143359890 |
ADAMTS18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143360102 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433607345 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS1433612344 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1433614577 |
AKR1D1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital bile acid synthesis defect 2, Congenital bile acid synthesis defect 2 |
| RS143361850 |
WNK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS143362532 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS143362935 |
ACP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloenchondrodysplasia with immune dysregulation, Inborn genetic diseases |
| RS143365075 |
WDR13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433656857 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS1433664240 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS143366614 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, CFI-related disorder |
| RS143366878 |
BBS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 10 |
| RS143367518 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome |
| RS1433680488 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS143368111 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Van Maldergem syndrome 1 |
| RS143368521 |
MAPKBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MAPKBP1-related disorder |
| RS143368674 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Tibial muscular dystrophy |
| RS143370284 |
ZEB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |